TY - JOUR T1 - Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination JF - BMJ Case Reports JO - BMJ Case Reports DO - 10.1136/bcr-2021-242220 VL - 14 IS - 5 SP - e242220 AU - Omar Fueyo-Rodriguez AU - Benjamin Valente-Acosta AU - Rodolfo Jimenez-Soto AU - Yvette Neme-Yunes AU - Sergio Ignacio Inclán-Alarcón AU - Roxana Trejo-Gonzalez AU - Miguel Ángel García-Salcido Y1 - 2021/05/01 UR - http://casereports.bmj.com/content/14/5/e242220.abstract N2 - Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer–BioNTech). ER -